The currently available anti-LYVE-1 antibodies allow for in vivo fluorescence imaging of lymphatic vessels and the disseminating tumour cells [300], and are used for positron emission tomography (PET) scanning [301]. The gene discussed is LYVE1; the disease is neoplasm.